Navigation Links
Results of Two Phase 3 CAPACITY Studies of Pirfenidone in IPF Presented at American Thoracic Society (ATS)
Date:5/19/2009

is is two to five years, with a five-year survival rate of approximately 20%. Patients diagnosed with IPF are usually between the ages of 40 and 70, with a median age of 63 years and the disease tends to affect slightly more men than women. There are no medicines approved by the FDA or EMEA for the treatment of IPF.

Webcast Details

InterMune will host a teleconference and webcast, with accompanying slide presentation, this evening at 9:00 p.m. EDT (6:00 p.m. PDT), in which Dr. Noble will present his oral presentation of the CAPACITY results and accompanying slides.

To access the live teleconference, dial 888-799-0528 (U.S.) or 973-200-3372 (international), conference ID# 97738057. To access the live audio webcast of the conference call, please log on to the investor relations page of the company's website at www.intermune.com. The company recommends logging on to the site 15 minutes prior to the start of the presentation in order to register or download any necessary software.

A replay of the webcast and teleconference will be available approximately three hours after the call. The teleconference replay will be available for 10 business days following the call and can be accessed by dialing 800-642-1687 (U.S.) or 706-645-9291 (international), and entering the conference ID# 97738057.

About InterMune

InterMune is a biotechnology company focused on the research, development and commercialization of innovative therapies in pulmonology and hepatology. InterMune has a pipeline portfolio addressing idiopathic pulmonary fibrosis (IPF) and hepatitis C virus (HCV) infections. The pulmonology portfolio includes the Phase 3 program, CAPACITY, which is evaluating pirfenidone as a possible therapeutic candidate for the treatment of patients with IPF, RECAP, an open-label extension study from CAPACITY and a resear
'/>"/>

SOURCE InterMune, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. Shire Announces Study Results of the Effects of INTUNIV(TM) (Guanfacine) Extended Release on Secondary Measures in Children with ADHD and Oppositional Symptoms
2. Optimer Pharmaceuticals Presents Results From Fidaxomicin Phase 3 Study for the Treatment of Clostridium difficile Infection
3. BioVex to Report Phase I/II Clinical Trial Results for the Front Line Treatment of Head and Neck Cancer With OncoVEX GM-CSF at the 2009 American Society of Clinical Oncology Meeting
4. TYRX Presents Early Clinical Results from AIGISRX(TM) Antibacterial Envelope Retrospective Registry
5. Metabolic Solutions Development Company Announces Preliminary Results from Phase IIa Clinical Trial
6. AlphaVax Announces Promising Results in Melanoma Studies
7. Ongoing Landmark ROADMAP Study Demonstrates Significant Improvement in Blood Pressure Control at One Year, According to Blinded Results
8. BioCryst Provides Peramivir Update and Reports First Quarter 2009 Financial Results
9. Bionovo Announces First Quarter 2009 Highlights and Financial Results
10. Alexza Reports 2009 First Quarter Financial Results and Updates Clinical Pipeline Status
11. ADVENTRX Announces Results From ANX-514 Bioequivalence Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)...  Cyberonics, Inc. (NASDAQ: CYBX ), a ... management of epilepsy, today announced it will participate in ... 2015, in Miami . ... Officer, will speak at 1:05 PM Eastern Time.  The ... and no formal materials will be presented.  A live ...
(Date:3/3/2015)... March 3, 2015  The eleventh annual Tucson Symposium ... the world,s top research scientists, academics, oncologists and pathologists ... and learn about new outcomes in patient treatments that ... Each year Ventana Medical Systems, Inc. (Ventana), ... the Tucson Symposium at the Hilton El Conquistador in ...
(Date:3/3/2015)... , March 3, 2015 /CNW/ - ChipCare Corporation, ... handheld, blood-testing platform for HIV and other infectious ... Series A financing to bring its first-generation product ... generation products. (Photo: http://photos.prnewswire.com/prnh/20150303/179107 ... health settings to simple, accurate and affordable diagnostic ...
Breaking Medicine Technology:Global scientific collaborators to explore latest pathology and oncology advancements at Tucson Symposium 2ChipCare Closes Oversubscribed $5 Million Series A Financing 2ChipCare Closes Oversubscribed $5 Million Series A Financing 3
(Date:3/3/2015)... 2015 Claflin Medical Equipment, ... Veterans Affairs has signed a new, five year contract ... , Under the contract, the company will provide ... U.S. Military, Indian Health Services, National Institute of Health, ... with competitive pricing for hospital equipment and related services. ...
(Date:3/3/2015)... Miami, FL (PRWEB) March 03, 2015 ... reversal of type I diabetes, type II diabetes, and ... in 30 Days offers a way for diabetes sufferers ... treatments or pharmaceutical drugs. , In 2013, the ... diabetes sufferers. These pharmaceutical treatments often include the use ...
(Date:3/3/2015)... March 03, 2015 T-System Inc. ... BSN, MBA, CEN, CPHQ, FABC as the company’s chief ... innovation for unscheduled, episodic care. , “Today’s ... episodic care settings including urgent care and freestanding emergency ... healthcare,” said Roger Davis, T-System’s chief executive officer. ...
(Date:3/3/2015)... March 03, 2015 The Data 360 ... at the Ford Conference Center, Dearborn, MI, on March 5, ... Inc., is a featured speaker. He is known internationally as ... , These designations were earned due to years of ... commercially-available NoSQL DB, released over 10 years ago. Subsequent developments ...
(Date:3/3/2015)... The authors Tracey Webb and Richard Mowbray ... future is a good and healthy diet . In ... have a created an ingenious book that shows readers how ... vegan meals. , “Crude Food” shows readers that, in modern ... caused by over processed refined foods , such as ...
Breaking Medicine News(10 mins):Health News:Claflin Medical Equipment (CME) Announces New 5 Year Contract with the Department of Veterans Affairs (VA) 2Health News:New Breakthrough In Diabetes Reaserch Show Scientifically Proven Way To Reverse Your Diabetes Naturally In 30 Short Days 2Health News:T-System Renews Commitment to Clinically-Driven Innovation and Appoints Industry Leader as CNO 2Health News:T-System Renews Commitment to Clinically-Driven Innovation and Appoints Industry Leader as CNO 3Health News:Scientel® to Present at Data 360 Big Data Healthcare Conference, March 5, 2015, Dearborn, MI 2Health News:Scientel® to Present at Data 360 Big Data Healthcare Conference, March 5, 2015, Dearborn, MI 3Health News:Scientel® to Present at Data 360 Big Data Healthcare Conference, March 5, 2015, Dearborn, MI 4Health News:New book ‘Crude Food’ gives readers ingenious ways to create healthy meals 2Health News:New book ‘Crude Food’ gives readers ingenious ways to create healthy meals 3
... 15 to 21 Percent, FRANKLIN LAKES, N.J., Nov. 5 , ... to a record $0.58 from $0.39 in ... intangible assets from the 2003 spin-off, increased ... third-quarter 2007 -- Both GAAP diluted EPS, and diluted EPS ...
... N.J., Nov. 5 BD (Becton,Dickinson and Company) (NYSE: ... Forlenza as President, effective January 1, 2009, and David ... effective,December 1, 2008., Mr. Forlenza will report to ... Executive Officer. Mr. Elkins will also report to Mr.,Ludwig. ...
... LAKES, N.J., Nov. 5 BD (Becton,Dickinson and Company) ... billion for the fourth fiscal quarter ended September 30, ... year period. This,quarter,s growth rate reflects the favorable impact ... estimated to account for 5,percentage points of the increase ...
... Nov. 5 Californians for SAFE Food, the,statewide ... extends sincere,gratitude to the California family farmers, food ... labor and community,groups who lent their energy, expertise ... The Yes on 2 campaign, backed by ...
... asset impairment charge, - Improvements beginning to be ... The Providence Service,Corporation (Nasdaq: PRSC ) today ... 30, 2008. Included in the results is an estimated ... charge related,to the Company,s goodwill and certain of its ...
... a new report from Harvard Medical School. The report, Viruses and Infectious ... and urges adults to seek out new vaccines and renew their old ... ... are not up to date on their vaccinations, says a new report ...
Cached Medicine News:Health News:Medco Reports Record Third-Quarter 2008 GAAP Diluted EPS of $0.58; Diluted EPS Excluding Amortization of Intangible Assets of $0.63 2Health News:Medco Reports Record Third-Quarter 2008 GAAP Diluted EPS of $0.58; Diluted EPS Excluding Amortization of Intangible Assets of $0.63 3Health News:Medco Reports Record Third-Quarter 2008 GAAP Diluted EPS of $0.58; Diluted EPS Excluding Amortization of Intangible Assets of $0.63 4Health News:Medco Reports Record Third-Quarter 2008 GAAP Diluted EPS of $0.58; Diluted EPS Excluding Amortization of Intangible Assets of $0.63 5Health News:Medco Reports Record Third-Quarter 2008 GAAP Diluted EPS of $0.58; Diluted EPS Excluding Amortization of Intangible Assets of $0.63 6Health News:Medco Reports Record Third-Quarter 2008 GAAP Diluted EPS of $0.58; Diluted EPS Excluding Amortization of Intangible Assets of $0.63 7Health News:Medco Reports Record Third-Quarter 2008 GAAP Diluted EPS of $0.58; Diluted EPS Excluding Amortization of Intangible Assets of $0.63 8Health News:Medco Reports Record Third-Quarter 2008 GAAP Diluted EPS of $0.58; Diluted EPS Excluding Amortization of Intangible Assets of $0.63 9Health News:Medco Reports Record Third-Quarter 2008 GAAP Diluted EPS of $0.58; Diluted EPS Excluding Amortization of Intangible Assets of $0.63 10Health News:Medco Reports Record Third-Quarter 2008 GAAP Diluted EPS of $0.58; Diluted EPS Excluding Amortization of Intangible Assets of $0.63 11Health News:Medco Reports Record Third-Quarter 2008 GAAP Diluted EPS of $0.58; Diluted EPS Excluding Amortization of Intangible Assets of $0.63 12Health News:Medco Reports Record Third-Quarter 2008 GAAP Diluted EPS of $0.58; Diluted EPS Excluding Amortization of Intangible Assets of $0.63 13Health News:Medco Reports Record Third-Quarter 2008 GAAP Diluted EPS of $0.58; Diluted EPS Excluding Amortization of Intangible Assets of $0.63 14Health News:Medco Reports Record Third-Quarter 2008 GAAP Diluted EPS of $0.58; Diluted EPS Excluding Amortization of Intangible Assets of $0.63 15Health News:Medco Reports Record Third-Quarter 2008 GAAP Diluted EPS of $0.58; Diluted EPS Excluding Amortization of Intangible Assets of $0.63 16Health News:Medco Reports Record Third-Quarter 2008 GAAP Diluted EPS of $0.58; Diluted EPS Excluding Amortization of Intangible Assets of $0.63 17Health News:Medco Reports Record Third-Quarter 2008 GAAP Diluted EPS of $0.58; Diluted EPS Excluding Amortization of Intangible Assets of $0.63 18Health News:Medco Reports Record Third-Quarter 2008 GAAP Diluted EPS of $0.58; Diluted EPS Excluding Amortization of Intangible Assets of $0.63 19Health News:Medco Reports Record Third-Quarter 2008 GAAP Diluted EPS of $0.58; Diluted EPS Excluding Amortization of Intangible Assets of $0.63 20Health News:Medco Reports Record Third-Quarter 2008 GAAP Diluted EPS of $0.58; Diluted EPS Excluding Amortization of Intangible Assets of $0.63 21Health News:Medco Reports Record Third-Quarter 2008 GAAP Diluted EPS of $0.58; Diluted EPS Excluding Amortization of Intangible Assets of $0.63 22Health News:Medco Reports Record Third-Quarter 2008 GAAP Diluted EPS of $0.58; Diluted EPS Excluding Amortization of Intangible Assets of $0.63 23Health News:Medco Reports Record Third-Quarter 2008 GAAP Diluted EPS of $0.58; Diluted EPS Excluding Amortization of Intangible Assets of $0.63 24Health News:Medco Reports Record Third-Quarter 2008 GAAP Diluted EPS of $0.58; Diluted EPS Excluding Amortization of Intangible Assets of $0.63 25Health News:Medco Reports Record Third-Quarter 2008 GAAP Diluted EPS of $0.58; Diluted EPS Excluding Amortization of Intangible Assets of $0.63 26Health News:Medco Reports Record Third-Quarter 2008 GAAP Diluted EPS of $0.58; Diluted EPS Excluding Amortization of Intangible Assets of $0.63 27Health News:Medco Reports Record Third-Quarter 2008 GAAP Diluted EPS of $0.58; Diluted EPS Excluding Amortization of Intangible Assets of $0.63 28Health News:Medco Reports Record Third-Quarter 2008 GAAP Diluted EPS of $0.58; Diluted EPS Excluding Amortization of Intangible Assets of $0.63 29Health News:Medco Reports Record Third-Quarter 2008 GAAP Diluted EPS of $0.58; Diluted EPS Excluding Amortization of Intangible Assets of $0.63 30Health News:Medco Reports Record Third-Quarter 2008 GAAP Diluted EPS of $0.58; Diluted EPS Excluding Amortization of Intangible Assets of $0.63 31Health News:BD Announces Executive Appointments of President and Chief Financial Officer 2Health News:BD Announces Executive Appointments of President and Chief Financial Officer 3Health News:BD Announces Results for Fourth Fiscal Quarter and Full Year 2Health News:BD Announces Results for Fourth Fiscal Quarter and Full Year 3Health News:BD Announces Results for Fourth Fiscal Quarter and Full Year 4